Skip to content
OpenCapital
Get started

United Therapeutics UTHR Operating Income

Operating Income at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$1.3B+37.4%
Insmed logo
InsmedINSM
-$153.32M+38.2%
Ethos Technologies, Inc. logo
Ethos Technologies, Inc. LIFE
-$11.44M+27.5%
LQD
Liquidia CorporationLQDA
$61.5M+274%
Amgen logo
AmgenAMGN
$2.67B+126%
Johnson & Johnson logo
Johnson & JohnsonJNJ
——

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M—
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23B+84.1%
P/E17.9×+7.8×
P/S7.3×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity0×—
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's operating income?
United Therapeutics (UTHR) reported operating income of $325.8M in Q1 2026.
How has United Therapeutics's operating income changed year-over-year?
United Therapeutics's operating income decreased by 14.9% year-over-year, from $382.8M to $325.8M.
What is the long-term trend for United Therapeutics's operating income?
Over 4 years (2021 to 2025), United Therapeutics's operating income has grown at a 28.0% compound annual growth rate (CAGR), from $555.9M to $1.49B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.